{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:38:49Z","timestamp":1789144729630,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05375-7","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:24:37Z","timestamp":1768821877000},"page":"3830-3840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Qualitative and quantitative analysis of enhanced computed tomography in differentiating and grading pancreatic neuroendocrine neoplasms: a multicenter study"],"prefix":"10.1007","volume":"51","author":[{"given":"Haiyu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingquan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"5375_CR1","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s40618-022-01985-2","volume":"46","author":"X Liu","year":"2022","unstructured":"Liu X, Chen B, Chen J, Su Z and Sun S. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. Journal of Endocrinological Investigation 2022;46:1373\u201384.","journal-title":"Journal of Endocrinological Investigation"},{"key":"5375_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","volume":"27","author":"MB Sonbol","year":"2022","unstructured":"Sonbol MB, Mazza GL, Mi L, et al. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis. The Oncologist 2022;27:573\u20138.","journal-title":"The Oncologist"},{"key":"5375_CR3","unstructured":"David S. Klimstra, Anthony J. Gill, G\u00fcnter Kl\u00f6ppel, Guido Rindi and Asa SL. Pancreatic neuroendocrine neoplasms: Introduction. In: WHO Classification of Tumours Editorial Board (eds). WHO classification of endocrine and neuroendocrine tumours [Internet]. Lyon, France: International Agency for Research on Cancer; 2022."},{"key":"5375_CR4","unstructured":"Kl\u00f6ppel G, Adsay NV, Couvelard A, et al. Pancreatic neuroendocrine neoplasms:Introduction. In: WHO Classification of Tumours Editorial Board (eds). Lyon, France: International Agency for Research on Cancer; 2019:343\u20136."},{"key":"5375_CR5","doi-asserted-by":"crossref","unstructured":"Wu Z, Qiu X, Zhi Y, Shi X and Lv G. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database. Frontiers in Oncology 2022;12.","DOI":"10.3389\/fonc.2022.993524"},{"key":"5375_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5306\/wjco.v8.i3.293","volume":"8","author":"M Sugimoto","year":"2017","unstructured":"Sugimoto M, Takagi T, Suzuki R, et al. Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series. World J Clin Oncol 2017;8:293\u20139.","journal-title":"World J Clin Oncol"},{"key":"5375_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/bjs\/znab088","volume":"108","author":"CM Heidsma","year":"2021","unstructured":"Heidsma CM, Engelsman AF, van Dieren S, et al. Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA). British Journal of Surgery 2021;108:888\u201391.","journal-title":"British Journal of Surgery"},{"key":"5375_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2020;31:844\u201360.","journal-title":"Annals of Oncology"},{"key":"5375_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Annals of Oncology 2013;24:152\u201360.","journal-title":"Annals of Oncology"},{"key":"5375_CR10","doi-asserted-by":"crossref","unstructured":"Pulvirenti A, Raj N, Cingarlini S, et al. Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms. Pancreas 2021;50:138\u2009\u2013\u200946.","DOI":"10.1097\/MPA.0000000000001740"},{"key":"5375_CR11","doi-asserted-by":"publisher","first-page":"053","DOI":"10.1055\/s-0040-1708070","volume":"3","author":"S Kapur","year":"2020","unstructured":"Kapur S, Sharma R and Goyal A. Imaging in Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal and Abdominal Radiology 2020;3:053\u201363.","journal-title":"Journal of Gastrointestinal and Abdominal Radiology"},{"key":"5375_CR12","doi-asserted-by":"crossref","unstructured":"P\u00f3\u0142torak-Szymczak G, Budlewski T, Furmanek MI, et al. Radiological Imaging of Gastro-Entero-Pancreatic Neuroendocrine Tumors. The Review of Current Literature Emphasizing the Diagnostic Value of Chosen Imaging Methods. Frontiers in Oncology 2021;11.","DOI":"10.3389\/fonc.2021.670233"},{"key":"5375_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin A, Arnold R, Baudin E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. Neuroendocrinology 2017;105:212\u201344.","journal-title":"Neuroendocrinology"},{"key":"5375_CR14","doi-asserted-by":"publisher","first-page":"e1284-e90","DOI":"10.1097\/SLA.0000000000005390","volume":"277","author":"AA Javed","year":"2023","unstructured":"Javed AA, Pulvirenti A, Razi S, et al. Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-institutional Study. Ann Surg 2023;277:e1284-e90.","journal-title":"Ann Surg"},{"key":"5375_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.diii.2020.06.006","volume":"101","author":"A Azoulay","year":"2020","unstructured":"Azoulay A, Cros J, Vullierme MP, et al. Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma. Diagnostic and Interventional Imaging 2020;101:821\u201330.","journal-title":"Diagnostic and Interventional Imaging"},{"key":"5375_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2214\/AJR.17.18417","volume":"210","author":"R Canellas","year":"2018","unstructured":"Canellas R, Burk KS, Parakh A and Sahani DV. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. American Journal of Roentgenology 2018;210:341\u20136.","journal-title":"American Journal of Roentgenology"},{"key":"5375_CR17","doi-asserted-by":"crossref","unstructured":"Yu H, Li M, Cao D, et al. Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5%. European Journal of Radiology 2022;147.","DOI":"10.1016\/j.ejrad.2021.110100"},{"key":"5375_CR18","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1007\/s00330-022-09351-9","volume":"33","author":"M Mori","year":"2022","unstructured":"Mori M, Palumbo D, Muffatti F, et al. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features. European Radiology 2022;33:4412\u201321.","journal-title":"European Radiology"},{"key":"5375_CR19","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1007\/s00330-020-06867-w","volume":"30","author":"HJ Park","year":"2020","unstructured":"Park HJ, Kim HJ, Kim KW, et al. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT. European Radiology 2020;30:4772\u201382.","journal-title":"European Radiology"},{"key":"5375_CR20","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s00330-015-3943-5","volume":"26","author":"DW Kim","year":"2015","unstructured":"Kim DW, Kim HJ, Kim KW, et al. Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. European Radiology 2015;26:1320\u20139.","journal-title":"European Radiology"},{"key":"5375_CR21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00330-015-3941-7","volume":"26","author":"JH Kim","year":"2016","unstructured":"Kim JH, Eun HW, Kim YJ, Lee JM, Han JK and Choi BI. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol 2016;26:1338\u201347.","journal-title":"Eur Radiol"},{"key":"5375_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11604-017-0627-x","volume":"35","author":"F Toshima","year":"2017","unstructured":"Toshima F, Inoue D, Komori T, et al. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? Jpn J Radiol 2017;35:242\u201353.","journal-title":"Jpn J Radiol"},{"key":"5375_CR23","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ejso.2022.05.016","volume":"48","author":"Z Yang","year":"2022","unstructured":"Yang Z and Shi G. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database. European Journal of Surgical Oncology 2022;48:2181\u20137.","journal-title":"European Journal of Surgical Oncology"},{"key":"5375_CR24","doi-asserted-by":"crossref","unstructured":"Kos-Kud\u0142a B, Casta\u00f1o JP, Denecke T, et al. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. Journal of Neuroendocrinology 2023;35.","DOI":"10.1111\/jne.13343"},{"key":"5375_CR25","doi-asserted-by":"publisher","first-page":"W283-90","DOI":"10.2214\/AJR.12.8941","volume":"200","author":"S Kawamoto","year":"2013","unstructured":"Kawamoto S, Johnson PT, Shi C, et al. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. AJR Am J Roentgenol 2013;200:W283-90.","journal-title":"AJR Am J Roentgenol"},{"key":"5375_CR26","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1097\/PAS.0b013e31826a0048","volume":"36","author":"AD Singhi","year":"2012","unstructured":"Singhi AD, Chu LC, Tatsas AD, et al. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol 2012;36:1666\u201373.","journal-title":"Am J Surg Pathol"},{"key":"5375_CR27","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00330-013-2929-4","volume":"23","author":"R Manfredi","year":"2013","unstructured":"Manfredi R, Bonatti M, Mantovani W, et al. Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour. European Radiology 2013;23:3029\u201339.","journal-title":"European Radiology"},{"key":"5375_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2214\/AJR.11.8037","volume":"200","author":"A Gallotti","year":"2013","unstructured":"Gallotti A, Johnston RP, Bonaffini PA, et al. Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. AJR Am J Roentgenol 2013;200:355\u201362.","journal-title":"AJR Am J Roentgenol"},{"key":"5375_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7555\/JBR.34.20200039","volume":"35","author":"W Xu","year":"2020","unstructured":"Xu W, Yan H, Xu L, et al. Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms. J Biomed Res 2020;35:179\u201388.","journal-title":"J Biomed Res"},{"key":"5375_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MPA.0000000000000443","volume":"45","author":"S Yamada","year":"2016","unstructured":"Yamada S, Fujii T, Suzuki K, et al. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography. Pancreas 2016;45:198\u2013203.","journal-title":"Pancreas"},{"key":"5375_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.hpb.2017.06.013","volume":"19","author":"GA Zamboni","year":"2017","unstructured":"Zamboni GA, Ambrosetti MC, Zivelonghi C, et al. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology. Hpb 2017;19:986\u201391.","journal-title":"Hpb"},{"key":"5375_CR32","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1007\/s00330-014-3317-4","volume":"24","author":"Y Luo","year":"2014","unstructured":"Luo Y, Dong Z, Chen J, et al. Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification. Eur Radiol 2014;24:2945\u201352.","journal-title":"Eur Radiol"},{"key":"5375_CR33","doi-asserted-by":"crossref","unstructured":"Kang J, Ryu JK, Son JH, et al. Association between pathologic grade and multiphase computed tomography enhancement in pancreatic neuroendocrine neoplasm. J Gastroenterol Hepatol 2018.","DOI":"10.1111\/jgh.14139"},{"key":"5375_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jgh.13594","volume":"32","author":"S Horiguchi","year":"2017","unstructured":"Horiguchi S, Kato H, Shiraha H, et al. Dynamic computed tomography is useful for prediction of pathological grade in pancreatic neuroendocrine neoplasm. J Gastroenterol Hepatol 2017;32:925\u201331.","journal-title":"J Gastroenterol Hepatol"},{"key":"5375_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11605-009-1115-0","volume":"14","author":"J Franko","year":"2010","unstructured":"Franko J, Feng W, Yip L, Genovese E and Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 2010;14:541\u20138.","journal-title":"J Gastrointest Surg"},{"key":"5375_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","volume":"38","author":"O Basturk","year":"2014","unstructured":"Basturk O, Tang L, Hruban RH, et al. Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas. American Journal of Surgical Pathology 2014;38:437\u201347.","journal-title":"American Journal of Surgical Pathology"},{"key":"5375_CR37","doi-asserted-by":"publisher","first-page":"e2124750","DOI":"10.1001\/jamanetworkopen.2021.24750","volume":"4","author":"Z Xu","year":"2021","unstructured":"Xu Z, Wang L, Dai S, et al. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States. JAMA Netw Open 2021;4:e2124750.","journal-title":"JAMA Netw Open"},{"key":"5375_CR38","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0016-5085(03)01198-3","volume":"125","author":"A-M Marion-Audibert","year":"2003","unstructured":"Marion-Audibert A-M, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003;125:1094\u2013104.","journal-title":"Gastroenterology"},{"key":"5375_CR39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s00261-018-1763-1","volume":"44","author":"C Guo","year":"2018","unstructured":"Guo C, Zhuge X, Wang Z, et al. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade. Abdominal Radiology 2018;44:576\u201385.","journal-title":"Abdominal Radiology"},{"key":"5375_CR40","unstructured":"Bosman FT, Carneiro F, Hruban RH and al. e. WHO classification of tumours of the digestive system. Lyon, France: International Agency for Research on Cancer; 2010."},{"key":"5375_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000090026","volume":"6","author":"M Rodallec","year":"2006","unstructured":"Rodallec M, Vilgrain V, Couvelard A, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 2006;6:77\u201385.","journal-title":"Pancreatology"},{"key":"5375_CR42","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1007\/s00330-022-08891-4","volume":"32","author":"H-Y Chen","year":"2022","unstructured":"Chen H-Y, Pan Y, Chen J-Y, et al. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. European Radiology 2022;32:8317\u201325.","journal-title":"European Radiology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05375-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05375-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05375-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:02:15Z","timestamp":1784883735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05375-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5375"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05375-7","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}